Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally advanced, ...

A little more than a month after AstraZeneca jumped into the fray with the purchase of a rival heart drug candidate, Eli ...

AstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

While there is more uncertainty for markets ahead, Barclays' analysts still highlight a number of stocks in which they see ...

AstraZeneca Pharma India rose 1.84% to Rs 6,515.50 after the durg maker said that it will launch Breztri Aerosphere in January 2025 in India.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso ...

Nice said it was ‘extremely disappointed’ it will be unable to recommend trastuzumab deruxtecan, sold under the brand name ...

The National Institute for Health and Care Excellence (Nice) said it is "extremely disappointed" it will be unable to ...

The billionaire Poonawalla family have bought a £42mn building in London’s upmarket Grosvenor Square, around the corner from their Mayfair home, despite concerns that changes to the UK’s non-dom tax ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...